Cargando…

Markers of Aggressiveness in Pituitary Tumors: Update and Perspectives

Detalles Bibliográficos
Autores principales:	Bioletto, Fabio, Berton, Alessandro Maria, Prencipe, Nunzia, Varaldo, Emanuele, Bona, Chiara, Grottoli, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658464/ https://www.ncbi.nlm.nih.gov/pubmed/36362740 http://dx.doi.org/10.3390/jcm11216508

Ejemplares similares

Isolated anterior pituitary dysfunction in adulthood
por: Prencipe, Nunzia, et al.
Publicado: (2023)

Attuali applicazioni della determinazione dei livelli plasmatici di copeptina in contesti non-endocrinologici
por: Berton, Alessandro Maria, et al.
Publicado: (2022)

MRI Assessment of Cardiac Function and Morphology in Adult Patients With Growth Hormone Deficiency: A Systematic Review and Meta-Analysis
por: Bioletto, Fabio, et al.
Publicado: (2022)

Development and Internal Validation of a Predictive Model for Adult GH Deficiency Prior to Stimulation Tests
por: Bioletto, Fabio, et al.
Publicado: (2021)

GHRH + arginine test and body mass index: do we need to review diagnostic criteria for GH deficiency?
por: Gasco, V., et al.
Publicado: (2023)

Development and internal validation of a predictive score for the diagnosis of central adrenal insufficiency when morning cortisol is in the grey zone
por: Bioletto, F., et al.
Publicado: (2022)

Neuroendocrine response to diclofenac in healthy subjects: a pilot study
por: Varaldo, E., et al.
Publicado: (2023)

Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study
por: Berton, Alessandro Maria, et al.
Publicado: (2023)

Mean GH profile is more accurate than single fasting GH in the evaluation of acromegaly disease control during somatostatin receptor ligands therapy
por: Bona, C., et al.
Publicado: (2022)

Endocrine disrupting chemicals: effects on pituitary, thyroid and adrenal glands
por: Egalini, Filippo, et al.
Publicado: (2022)

Idiopathic Urethral Stricture and Nephrogenic Diabetes Insipidus: The Odd Couple
por: Berton, Alessandro Maria, et al.
Publicado: (2019)

Association of Urine Metanephrine Levels with CardiometaBolic Risk: An Observational Retrospective Study
por: Parasiliti-Caprino, Mirko, et al.
Publicado: (2021)

Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study
por: Berton, Alessandro Maria, et al.
Publicado: (2022)

Traumatic Brain Injury as Frequent Cause of Hypopituitarism and Growth Hormone Deficiency: Epidemiology, Diagnosis, and Treatment
por: Gasco, Valentina, et al.
Publicado: (2021)

Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view
por: Berton, A. M., et al.
Publicado: (2020)

Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment
por: Prencipe, N., et al.
Publicado: (2020)

Aggressive Pituitary Tumors and Pituitary Carcinomas: From Pathology to Treatment
por: Burman, Pia, et al.
Publicado: (2023)

Correction to “Aggressive Pituitary Tumors and Pituitary Carcinomas: From Pathology to Treatment”
Publicado: (2023)

Hypothalamic-Pituitary Autoimmunity and Traumatic Brain Injury
por: Guaraldi, Federica, et al.
Publicado: (2015)

Future treatment strategies of aggressive pituitary tumors
por: Lamberts, Steven W. J., et al.
Publicado: (2008)

The epidemiology of aggressive pituitary tumors (and its challenges)
por: Dekkers, Olaf M., et al.
Publicado: (2020)

Temozolomide in aggressive pituitary adenomas and carcinomas
por: Ortiz, Leon D., et al.
Publicado: (2012)

Multimodal Non-Surgical Treatments of Aggressive Pituitary Tumors
por: Nakano-Tateno, Tae, et al.
Publicado: (2021)

Pituitary metastases from neuroendocrine neoplasms: case report and narrative review
por: Ragni, Alberto, et al.
Publicado: (2021)

Surgical treatment of aggressive pituitary adenomas and pituitary carcinomas
por: Buchfelder, Michael, et al.
Publicado: (2020)

Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations
por: Casar-Borota, Olivera, et al.
Publicado: (2020)

Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors
por: Bianchi, Antonio, et al.
Publicado: (2023)

Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features
por: Vázquez-Borrego, Mari C., et al.
Publicado: (2019)

The Effects of Omega 3 and Omega 6 Fatty Acids on Glucose Metabolism: An Updated Review
por: Egalini, Filippo, et al.
Publicado: (2023)

Temozolomide Therapy for Aggressive Pituitary Tumors: Results in a Small Series of Patients from Argentina
por: Bruno, Oscar D., et al.
Publicado: (2015)

Pituitary Crooke Cell Adenoma: Two Cases of an Aggressive Pituitary Adenoma
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

Pituitary apoplexy: an update on clinical and imaging features
por: Boellis, Alessandro, et al.
Publicado: (2014)

An Update on Pituitary Neuroendocrine Tumors Leading to Acromegaly and Gigantism
por: Asa, Sylvia L., et al.
Publicado: (2021)

Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 1. Pituitary neuroendocrine tumor (PitNET)/pituitary adenoma
por: Tsukamoto, Taro, et al.
Publicado: (2023)

New Perspectives on Diagnostics, Prognosis, and Therapy in Aggressive Endocrine Tumours
por: Appetecchia, Marialuisa, et al.
Publicado: (2012)

Endotrophin – Linking Obesity with Aggressive Tumor Growth
por: Park, Jiyoung, et al.
Publicado: (2012)

Deregulation of miR-183 and KIAA0101 in Aggressive and Malignant Pituitary Tumors
por: Roche, Magali, et al.
Publicado: (2015)

Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience
por: Giuffrida, G, et al.
Publicado: (2019)

Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art
por: Feola, Tiziana, et al.
Publicado: (2022)

Clinical Efficacy of Temozolomide and Its Predictors in Aggressive Pituitary Tumors and Pituitary Carcinomas: A Systematic Review and Meta-Analysis
por: Luo, Mei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uj9eergu1utau3flnanjbqh2ie